Revenue

With a new board chair, regulatory backing, and an AI platform, GC Therapeutics is targeting MS and diabetes with next-generation cell therapies.

The biotech firm now expects Phase 2 results in Q3 2026, accelerating hope for new CNS treatments and signaling strong operational momentum to investors.

Indonesia Energy Corp. starts pre-drilling for two new wells in Sumatra, a key move in its growth strategy and a boost for national energy security.

Amid strong investor demand, VR Resources boosts its financing and plans a share consolidation to fuel its key copper, gold, and tungsten projects in Nevada.

Predis.ai's new AI promises to slash video ad costs and production time, empowering small businesses and challenging traditional marketing workflows.

Former mayoral candidate Luc Rabouin takes the helm at the $500M Foundation of Greater Montréal, bringing his urban development expertise to shape its future.

Upbound Group's new CEO and CFO head to the prestigious ICR Conference. Investors await insights on growth, credit trends, and financial inclusion strategy.

A new partnership integrates Lilly's powerful TuneLab AI into Schrödinger's LiveDesign, promising to accelerate R&D with a novel privacy-first approach.

In a move securing benefits for 400 retirees, Laurentian Bank transfers pension duties, reflecting a wider industry trend to reduce risk and simplify.

A new hotel on Palm Jumeirah challenges Dubai's opulent norms with a vision of calm and efficiency, guided by its enigmatic founder, Yasam Ayavefe.

Sanofi deepens its AI partnership with CytoReason in a $16M deal, signaling a major shift in using predictive models to accelerate immunology breakthroughs.

Surging NYC energy bills have homeowners facing a tough choice. Learn the key signs that your aging HVAC system needs replacement, not another costly repair.

Ocugen heads to a top investor conference with a bold plan for its gene-agnostic therapy, aiming to treat blindness and secure its future in a crowded market.

With blockbuster preliminary sales and rapid patient adoption, Liquidia's new inhaled therapy is challenging established players in the lung disease space.

The institutional crypto exchange reported a sharp decline in spot trading for December, but a massive surge in options volume points to a maturing market.

The acquisition combines autonomous ship platforms with advanced AI, creating an end-to-end solution aimed at dominating the future of maritime defense.

ChipMOS reports stunning 20.8% Q4 growth, highlighting a memory chip frenzy fueled by AI and datacenters. Is this the start of a new tech supercycle?

With a new $1.95B valuation, Rain's massive funding round led by ICONIQ signals institutional confidence in stablecoins as the future of global payments.

From a $2.3B real estate privatization to blockbuster retail earnings and a shifting job market, key corporate moves reveal a nation at a crossroads.

With support from a bipartisan alliance, nonprofit newsroom Votebeat is scaling up its expert reporting to fight election misinformation and bolster trust.